Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 07, 2016 08:05 ET | Source: Organovo, Inc.

Organovo Announces Initiation of Commercial Contracting for ExVive Human Kidney Tissue

SAN DIEGO, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
August 18, 2016 08:05 ET | Source: Organovo, Inc.

Organovo Appoints Two New Members to Board of Directors

SAN DIEGO, Aug. 18, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
August 04, 2016 16:10 ET | Source: Organovo, Inc.

Organovo Announces Fiscal First-Quarter 2017 Results; Company Affirms Full-Year Fiscal 2017 and Long-Range Outlook

SAN DIEGO, Aug. 04, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NYSE MKT:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
August 02, 2016 08:05 ET | Source: Organovo, Inc.

Organovo Announces Appointment of Craig Kussman as Chief Financial Officer

SAN DIEGO, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NYSE:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using...
July 26, 2016 08:05 ET | Source: Organovo, Inc.

Organovo to Begin Trading on Nasdaq Stock Market

SAN DIEGO, July 26, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NYSE:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using...
July 20, 2016 08:05 ET | Source: Organovo, Inc.

Organovo on Track to Commercialize Kidney Tissue; Company Signs First Customer Orders for Kidney Tissue Early Access Program

SAN DIEGO, July 20, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NYSE:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using...
July 14, 2016 08:05 ET | Source: Organovo, Inc.

Organovo Announces Release Date for Fiscal First-Quarter 2017 Financial Results

SAN DIEGO, July 14, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NYSE MKT:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
July 11, 2016 08:05 ET | Source: Organovo, Inc.

Organovo and Roche Researchers Publish Data Demonstrating Superiority of 3D Bioprinted Human Liver Tissues in Assessing Drug-Induced Toxicity

SAN DIEGO, July 11, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NYSE MKT:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
June 13, 2016 08:05 ET | Source: Organovo, Inc.

Organovo Collaborates With UCSF Team to Develop 3D Bioprinted Tissues for Skeletal Disease Research

SAN DIEGO, SAN FRANCISCO and SPRINGFIELD, Va., June 13, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NYSE MKT:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering...
June 09, 2016 16:05 ET | Source: Organovo, Inc.

Organovo Announces Fiscal Fourth-Quarter and Full-Year 2016 Results; Company Issues Full-Year Fiscal 2017 Outlook

SAN DIEGO, June 09, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NYSE MKT:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...